Open Access

[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer

  • Authors:
    • Katsuyuki Iida
    • Rong Zheng
    • Ruoqian Shen
    • David M. Nanus
  • View Affiliations

  • Published online on: September 16, 2024     https://doi.org/10.3892/ijo.2024.5694
  • Article Number: 106
  • Copyright : © Iida et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Int J Oncol 41: [Related article:] 1192-1198, 2012; DOI: 10.3892/ijo.2012.1586

Subsequently to the publication of the above article, an interested reader drew to the authors' attention that, for the immunostaining experiments shown in Fig. 3C on p. 1195, the 'NEP' and 'PTX' panels contained overlapping data, such that data which were intended to show the results of differently performed experiments had apparently been derived from the same original source.

After re-examining their original data, the authors have realized that the 'PTX' data panel in Fig. 3C had inadvertently been selected incorrectly. The revised and corrected version of Fig. 3, showing the correct data for the 'PTX' data panel in Fig. 3C, is shown on on the next page. The authors are grateful to the Editor of International Journal of Oncology for allowing them this opportunity to publish this Corrigendum, and all the authors agree with its publication. Furthermore, the authors apologize to the readership for any inconvenience caused.

Related Articles

Journal Cover

November-2024
Volume 65 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Iida K, Zheng R, Shen R and Nanus DM: [Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer. Int J Oncol 65: 106, 2024.
APA
Iida, K., Zheng, R., Shen, R., & Nanus, D.M. (2024). [Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer. International Journal of Oncology, 65, 106. https://doi.org/10.3892/ijo.2024.5694
MLA
Iida, K., Zheng, R., Shen, R., Nanus, D. M."[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer". International Journal of Oncology 65.5 (2024): 106.
Chicago
Iida, K., Zheng, R., Shen, R., Nanus, D. M."[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer". International Journal of Oncology 65, no. 5 (2024): 106. https://doi.org/10.3892/ijo.2024.5694